Who are Seres Therapeutics, Inc.'s main suppliers?

Seres Therapeutics, Inc. (MCRB) key suppliers include: 101-CPD-LLC, NESTL-ENTERPRISES-S-A, Enlivex Ltd., Myriad Genetics, Inc., Myriad Genetics, Inc. and 2 more. View the full supplier network at chainsifter.com/chain/MCRB.

Who are Seres Therapeutics, Inc.'s major customers?

Seres Therapeutics, Inc. (MCRB) key customers include: SOCI-T-DES-PRODUITS-NESTL-S-A, Myriad Genetics, Inc., Myriad Genetics, Inc., Theriva Biologics, Inc., Ventyx Biosciences Inc and 1 more. View the full customer network at chainsifter.com/chain/MCRB.

What sector is Seres Therapeutics, Inc. in?

Seres Therapeutics, Inc. (MCRB) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Seres Therapeutics, Inc. Suppliers, Customers & Supply Chain (MCRB)

7Suppliers

6Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

Seres Therapeutics, Inc. (MCRB) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

17Total relationships

4Distinct source URLs

7High confidence

0.789Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Seres Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
101-CPD-LLC	101-CPD-LLC	90%	the Company entered into the First Amendment to Lease with 101 CPD LLC (f/k/a HCP/King 101 CPD LLC), a Delaware limited liability company (the “Landlord”), which amends the Lease Agreement
NESTL-ENTERPRISES-S-A	NESTL-ENTERPRISES-S-A	90%	The Company entered into a Transition Services Agreement ("TSA") with Nestlé Enterprises S.A., ("NESA"), an affiliate of SPN, in connection with the Transaction, through which the Company provided ce…
ENLV	Enlivex Ltd.	72%	Reciprocal relationship from ENLV graph: fair value of share-based payment awards represent management’s best estimates, but the estimates involve inherent uncertainties and the application of manage…
MYGN	Myriad Genetics, Inc.	72%	, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation or other proceedings. In addition, during the course of this kind of liti…
MYGN	Myriad Genetics, Inc.	72%	Reciprocal relationship from MYGN graph: Reciprocal relationship from MCRB graph: , there is a risk that some of our confidential information could be compromised by disclosure during this type of li…
OCSL	Oaktree Specialty Lending Corporation	72%	Reciprocal relationship from OCSL graph: Reciprocal relationship from MCRB graph: Reciprocal relationship from OCSL graph: Reciprocal relationship from MCRB graph: Reciprocal relationship from OCSL g…
VTYX	Ventyx Biosciences Inc	72%	Reciprocal relationship from VTYX graph: Reciprocal relationship from MCRB graph: Reciprocal relationship from VTYX graph: Reciprocal relationship from MCRB graph: Reciprocal relationship from VTYX g…

Seres Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
SOCI-T-DES-PRODUITS-NESTL-S-A	SOCI-T-DES-PRODUITS-NESTL-S-A	92%	Pursuant to the Purchase Agreement, SPN agreed to pay the Company certain one-time contingent milestone payments during the Milestone Period
MYGN	Myriad Genetics, Inc.	72%	, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation or other proceedings. In addition, during the course of this kind of liti…
MYGN	Myriad Genetics, Inc.	72%	Reciprocal relationship from MYGN graph: Reciprocal relationship from MCRB graph: Reciprocal relationship from MYGN graph: Reciprocal relationship from MCRB graph: Reciprocal relationship from MYGN g…
TOVX	Theriva Biologics, Inc.	72%	Reciprocal relationship from TOVX graph: prescribe legally available drugs for off-label uses, drugs may be marketed only for the approved indications and in accordance with the provisions of the app…
VTYX	Ventyx Biosciences Inc	72%	Reciprocal relationship from VTYX graph: ls N.V., Landos Biopharma, Inc., Merck & Co., Inc., Morphic Therapeutic, Inc., Pfizer Inc., Protagonist Therapeutics, Inc., Theravance Biopharma, Inc., Pandio…
PLAB	Photronics, Inc.	62%	Reciprocal relationship from PLAB graph: Reciprocal relationship from MCRB graph: Reciprocal relationship from PLAB graph: Reciprocal relationship from MCRB graph: Reciprocal relationship from PLAB g…

Seres Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
MCRB-DEBT	Debt stack $110.0M	90%	Market cache reports total debt of $110.0M.
MCRB-DEBT-10898	Warrants outstanding: 2785000	90%	xbrl warrant detail from xbrl 2025-12-31.
MCRB-DEBT-10899	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2015-12-31.

Seres Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Seres Therapeutics, Inc..

Seres Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
MCRB-OWNER-FLAGSHIP-PIONEERING-LLC	Flagship Pioneering, LLC	90%	13F overlay lists Flagship Pioneering, LLC as top holder; 35 tracked holders.

Seres Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
IMNM	Immunome, Inc.	100.00	2
HOWL	Werewolf Therapeutics, Inc.	100.00	2
ATYR	aTyr Pharma, Inc.	100.00	2
ENLV	Enlivex Ltd.	100.00	1	['supplier']
BNBX	BNB Plus Corp.	100.00	2
PSNL	Personalis, Inc.	100.00	2
ELVN	Enliven Therapeutics, Inc.	100.00	2
DSGN	Design Therapeutics, Inc.	100.00	2
BIAF	bioAffinity Technologies, Inc.	100.00	2
ESTA	Establishment Labs Holdings Inc.	100.00	2
BNTC	Benitec Biopharma Inc.	100.00	2
CALC	CalciMedica, Inc.	100.00	2
ALLO	Allogene Therapeutics, Inc.	100.00	2
BIOA	BioAge Labs, Inc.	100.00	2
BTAI	BioXcel Therapeutics, Inc.	100.00	2
CLGN	CollPlant Biotechnologies Ltd.	100.00	2
CABA	Cabaletta Bio, Inc.	100.00	2
SDGR	Schrödinger, Inc.	100.00	2
ADCT	ADC Therapeutics SA	100.00	2
FBIO	Fortress Biotech, Inc.	100.00	2

Seres Therapeutics, Inc. Supply Chain